Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Todd Stravitz

Showing results (91-100 of 133) with videos related to

Pageof 14
Sort By:
Gastroenterology|August 27, 2013
Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesisM Shadab Siddiqui, Richard K Sterling, Velimir A Luketic, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menJennifer C Lai, Elizabeth C Verna, Robert S Brown, et al.
Gastroenterology|June 16, 2009
Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failureWilliam M Lee, Linda S Hynan, Lorenzo Rossaro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2010
Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samplesRichard K Sterling, Jacob A Wegelin, Paula G Smith, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2022
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysisConstantine J Karvellas, Thomas M Leventhal, Jorge L Rakela, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantationMitchell L Shiffman, R Todd Stravitz, Melissa J Contos, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 30, 2007
A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantationNevin Yilmaz, Mitchell L Shiffman, R Todd Stravitz, et al.
Clinical Transplantation|October 10, 2002
Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agentAdrian H Cotterell, Robert A Fisher, Anne L King, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation studyNorah A Terrault, R Todd Stravitz, Anna S F Lok, et al.
Gastroenterology|September 21, 2010
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathyJasmohan S Bajaj, Douglas M Heuman, James B Wade, et al.
Pageof 14

Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Gastroenterology|August 27, 2013
Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesisM Shadab Siddiqui, Richard K Sterling, Velimir A Luketic, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menJennifer C Lai, Elizabeth C Verna, Robert S Brown, et al.
Gastroenterology|June 16, 2009
Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failureWilliam M Lee, Linda S Hynan, Lorenzo Rossaro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2010
Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samplesRichard K Sterling, Jacob A Wegelin, Paula G Smith, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2022
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysisConstantine J Karvellas, Thomas M Leventhal, Jorge L Rakela, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantationMitchell L Shiffman, R Todd Stravitz, Melissa J Contos, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 30, 2007
A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantationNevin Yilmaz, Mitchell L Shiffman, R Todd Stravitz, et al.
Clinical Transplantation|October 10, 2002
Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agentAdrian H Cotterell, Robert A Fisher, Anne L King, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation studyNorah A Terrault, R Todd Stravitz, Anna S F Lok, et al.
Gastroenterology|September 21, 2010
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathyJasmohan S Bajaj, Douglas M Heuman, James B Wade, et al.
Pageof 14